Contemporary treatment of mitral valve disease with transcatheter mitral valve implantation.
Hendrik WienemannVictor MauriLaurin OchsMaria Isabel KörberKaveh EghbalzadehChristos IliadisMarcel HalbachThorsten WahlersStephan BaldusMatti AdamElmar KuhnPublished in: Clinical research in cardiology : official journal of the German Cardiac Society (2022)
In high-risk patients with MVD, TMVI presents a promising treatment option with encouraging mid-term outcomes and good valve durability. TMVI either with BAV or SAV may be developed to an established treatment option.